Erich Schlick

General Partner, Life Sciences at Wellington Partners GmbH

Erich Schlick

Erich Schlick

General Partner, Life Sciences at Wellington Partners GmbH

Overview
Career Highlights

BASF Pharma Ltd.

RelSci Relationships

3170

Number of Boards

16

Birthday

1952

Age

68

Contact Data
Trying to get in touch with Erich Schlick? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Erich Schlick likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Symetis SA

Relationship likelihood: Strong

Co-Founder at Actelion Pharmaceuticals

Relationship likelihood: Strong

Chief Executive Officer & Director at Sensimed SA

Relationship likelihood: Strong

Former Chief Financial Officer at Straumann Holding AG

Relationship likelihood: Strong

Co-Founder at dievini Hopp BioTech holding GmbH & Co. KG

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at OvaScience, Inc.

Relationship likelihood: Strong

General Partner, Legal Counsel at Wellington Partners GmbH

Relationship likelihood: Strong

General Partner & Board Member at MIG Verwaltungs AG

Relationship likelihood: Strong

Co-Founder & Managing Director at dievini Hopp BioTech holding GmbH & Co. KG

Relationship likelihood: Strong

Former Chief Executive Officer (Cambridge Antibody Technology Group Plc) at AstraZeneca Plc

Relationship likelihood: Strong

Paths to Erich Schlick
Potential Connections via
Relationship Science
You
Erich Schlick
General Partner, Life Sciences at Wellington Partners GmbH
Education
Undergraduate Degree in Medicine

Heidelberg University sees itself as a research university with a strong international orientation. Besides enhancing its disciplinary strengths, the University places special emphasis on maintaining the dialogue across traditional subject boundaries. Heidelberg University has twelve faculties with a total of more than 30,000 students and a research and teaching staff of more than 5,000 scientists - among them 450 professors. Numerous great minds have learned, taught and conducted research at Heidelberg University. The oldest German university has thus played an important part in shaping science and society since its founding in 1386. The University is at the centre of a research network that includes a large number of non-university research institutions and companies in Heidelberg and the Rhine-Neckar region.

MD Medicine

A COMMUNITY OF LEARNING THAT PROMOTES AND NURTURES INTELLECTUAL, PERSONAL AND PROFESSIONAL DEVELOPMENT LEADING TO A LIFE OF PURPOSE WITH DISTINCTION.

MD Medicine

Located on 110 beautiful acres in northwest Ohio, Heidelberg University combines a challenging liberal-arts curriculum with practical career preparation. Our welcoming, enthusiastic community includes over 1,000 undergraduate and 300 graduate students from all over the world, working closely with caring, insightful faculty members and staff. Heidelberg offers intellectually rigorous, hands-on courses in a wide range of majors, minors, concentrations, and pre-professional programs. We’re also home to the Life of the Mind Honors Program, the Center for Military and Historic Archeology, and the National Center for Water Quality Research —opportunities for study and engagement you won’t find anywhere else. Our energetic campus overflows with activities, including sports, clubs, musical performances, and Greek life. Heidelberg was founded in 1850 by the German Reformed Church (now United Church of Christ).

Memberships
Member
Current

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

Member
Current

The American Association of Immunologists is an association of professionally trained scientists from all over the world dedicated to advancing the knowledge of immunology and its related disciplines, fostering the interchange of ideas and information among investigators, and addressing the potential integration of immunologic principles into clinical practice. The American Association of Immunologists serves its members by providing a center for the dissemination of information relevant to the field and its practices, such as educational and professional opportunities, scientific meetings, membership-derived issues and opinions, and important social and political issues. AAI owns and publishes The Journal of Immunology—the largest and most highly cited journal in the field.

Fellow
Current

The Society of Kauffman Fellows is a network of venture capitalists operating at 160 venture firms and corporate venture groups in 26 countries on 6 continents, collectively deploying $50B in venture capital.

Career History
General Partner, Life Sciences
2005 - Current

WP specializes in the life sciences and technology sectors. They favor industries such as therapeutics, medical technology, diagnostics, digital media, distinctive electronics technology and software. The firm invests venture capital in young companies, including seed, startups, early-stage and expanding businesses. WP is a pan-European investor focused on northern, western and central Europe. The firm also marginally invests in the US. They follow a hands-on approach to promoting the growth of their portfolio companies. They build up management teams and provide business support without interfering in day-to-day operations.WP seeks to invest in companies with focused goals, significant international sales potential in high-growth markets, and whose products address the needs of customers likely to pay a premium. They aim to identify businesses with global market leadership potential, that are poised to create, embrace or exploit global technology trends.WP invests EUR 500 thousand to 20 million in the form of direct equity, and generally acquires minority stakes.

Executive Director-Worldwide Research
Current

Part of Abbott Laboratories, BASF Pharma Ltd. is a company headquartered in Kent, UK, that operates in the field of metabolic diseases, cardiovascular diseases, immunology, and pain therapy. The firm was founded by Erich Schlick. BASF Pharma Ltd. was acquired by Abbott Laboratories from BASF SE on 02 Mar 01 for $6,128.79 million.

Professor, Immunopharmacology
Current

Heidelberg University sees itself as a research university with a strong international orientation. Besides enhancing its disciplinary strengths, the University places special emphasis on maintaining the dialogue across traditional subject boundaries. Heidelberg University has twelve faculties with a total of more than 30,000 students and a research and teaching staff of more than 5,000 scientists - among them 450 professors. Numerous great minds have learned, taught and conducted research at Heidelberg University. The oldest German university has thus played an important part in shaping science and society since its founding in 1386. The University is at the centre of a research network that includes a large number of non-university research institutions and companies in Heidelberg and the Rhine-Neckar region.

Boards & Committees
Member-Supervisory Board
2015 - Current

ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany.

Director
Current

Winsor Coombs Chartered Professional Accountants provides accounting services. The company is headquartered in Mount Pear, Canada. immatics biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Member, Supervisory Board
Current
Director
Current

Heidelberg University sees itself as a research university with a strong international orientation. Besides enhancing its disciplinary strengths, the University places special emphasis on maintaining the dialogue across traditional subject boundaries. Heidelberg University has twelve faculties with a total of more than 30,000 students and a research and teaching staff of more than 5,000 scientists - among them 450 professors. Numerous great minds have learned, taught and conducted research at Heidelberg University. The oldest German university has thus played an important part in shaping science and society since its founding in 1386. The University is at the centre of a research network that includes a large number of non-university research institutions and companies in Heidelberg and the Rhine-Neckar region.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Erich Schlick. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Erich Schlick's profile does not indicate a business or promotional relationship of any kind between RelSci and Erich Schlick.